Why have Advance Directives failed in Spain?

Advance care planning Advance directive Living will

Journal

BMC medical ethics
ISSN: 1472-6939
Titre abrégé: BMC Med Ethics
Pays: England
ID NLM: 101088680

Informations de publication

Date de publication:
16 11 2020
Historique:
received: 11 08 2020
accepted: 29 10 2020
entrez: 17 11 2020
pubmed: 18 11 2020
medline: 29 7 2021
Statut: epublish

Résumé

In Spain, there has been great effort by lawmakers to put Advance Directives (ADs) into practice since 2002. At the same time, the field of bioethics has been on the rise, a discipline that has spurred debate on the right of patients to exercise their autonomy. Despite all this, the implementation of ADs can be said to have failed in Spain, because its prevalence is very low, there is a great lack of knowledge about them and they have very little impact on clinical decisions. The purpose of this article is to analyze and discuss the main reasons for the failure of ADs in Spain. The main reasons why ADs have no impact on clinical practice in Spain have been fundamentally four: (1) the training of health professionals about the end of life and AD is lacking; (2) there has been no public process to increase awareness about AD, and therefore people (with the exception of specific highly sensitized groups) know little about them; (3) the bureaucratic procedure to document and implement ADs is excessively complex and cumbersome, creating a significant barrier to their application; (4) in Spain, the remnants of a paternalistic medical culture continue to exist, which causes shared decision-making to be difficult. Due to the four reasons mentioned above, AD have not been a useful tool to help honor patients' autonomous decisions about their future care and, therefore, they have not achieved their objective. However, despite the difficulties and problems identified, it has also been observed that health care professionals and the Spanish public have a very positive view of AD. Having identified the problems which have kept AD from being successful, strategies must be developed to help improve their implementation into the future.

Sections du résumé

BACKGROUND
In Spain, there has been great effort by lawmakers to put Advance Directives (ADs) into practice since 2002. At the same time, the field of bioethics has been on the rise, a discipline that has spurred debate on the right of patients to exercise their autonomy. Despite all this, the implementation of ADs can be said to have failed in Spain, because its prevalence is very low, there is a great lack of knowledge about them and they have very little impact on clinical decisions. The purpose of this article is to analyze and discuss the main reasons for the failure of ADs in Spain.
MAIN BODY
The main reasons why ADs have no impact on clinical practice in Spain have been fundamentally four: (1) the training of health professionals about the end of life and AD is lacking; (2) there has been no public process to increase awareness about AD, and therefore people (with the exception of specific highly sensitized groups) know little about them; (3) the bureaucratic procedure to document and implement ADs is excessively complex and cumbersome, creating a significant barrier to their application; (4) in Spain, the remnants of a paternalistic medical culture continue to exist, which causes shared decision-making to be difficult.
CONCLUSION
Due to the four reasons mentioned above, AD have not been a useful tool to help honor patients' autonomous decisions about their future care and, therefore, they have not achieved their objective. However, despite the difficulties and problems identified, it has also been observed that health care professionals and the Spanish public have a very positive view of AD. Having identified the problems which have kept AD from being successful, strategies must be developed to help improve their implementation into the future.

Identifiants

pubmed: 33198746
doi: 10.1186/s12910-020-00557-4
pii: 10.1186/s12910-020-00557-4
pmc: PMC7667789
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113

Références

Bioethics. 1993 Apr;7(2-3):97-107
pubmed: 11651542
Gac Sanit. 2018 Jul - Aug;32(4):339-345
pubmed: 29110888
Camb Q Healthc Ethics. 2009 Summer;18(3):219-27
pubmed: 19460222
Gac Sanit. 2018 Jul - Aug;32(4):373-376
pubmed: 29221885
J Bioeth Inq. 2020 Sep;17(3):395-405
pubmed: 32725402
J Psychiatr Ment Health Nurs. 2019 Sep;26(7-8):223-232
pubmed: 31215746
Med Clin (Barc). 2010 Apr 10;134(10):448-51
pubmed: 19712945
Aten Primaria. 2017 Apr;49(4):233-239
pubmed: 27914719
Med Intensiva. 2016 Apr;40(3):154-62
pubmed: 26072095
Rev Clin Esp. 2011 Oct;211(9):450-4
pubmed: 21813119
An R Acad Nac Med (Madr). 1995;112(4):695-710
pubmed: 8678214
Rev Esp Cardiol. 2010 Dec;63(12):1410-8
pubmed: 21144401
Med Health Care Philos. 2012 Nov;15(4):437-51
pubmed: 22033813
Aten Primaria. 2010 Sep;42(9):463-9
pubmed: 20615580
Enferm Clin. 2008 May-Jun;18(3):115-9
pubmed: 18579060
Semergen. 2015 Apr;41(3):139-48
pubmed: 25002349
Nephrol Dial Transplant. 2017 Oct 1;32(10):1676-1682
pubmed: 28967968
Nefrologia. 2011;31(4):449-56
pubmed: 21738248
Med Clin (Barc). 2006 Apr 22;126(15):567-72
pubmed: 16756919
Rev Calid Asist. 2011 May-Jun;26(3):152-60
pubmed: 21459031
Lancet Oncol. 2017 Sep;18(9):e543-e551
pubmed: 28884703
Gac Sanit. 2010 Nov-Dec;24(6):437-45
pubmed: 21051116
Enferm Clin. 2020 Jan - Feb;30(1):16-22
pubmed: 31735459
Aten Primaria. 2003 Jun 15;32(1):30-5
pubmed: 12812688
Aten Primaria. 2017 May;49(5):278-285
pubmed: 27890302
Rev Clin Esp. 2010 Sep;210(8):379-88
pubmed: 20674892
J Bioeth Inq. 2016 Jun;13(2):295-303
pubmed: 26797513
Rev Clin Esp. 2014 Aug-Sep;214(6):296-302
pubmed: 24703989
Semergen. 2014 Apr;40(3):128-33
pubmed: 24433866
Aten Primaria. 2011 Jan;43(1):11-7
pubmed: 20304533
Med Intensiva. 2008 Apr;32(3):121-33
pubmed: 18381017
Rev Calid Asist. 2013 Sep-Oct;28(5):307-12
pubmed: 24021533
Aten Primaria. 2008 Feb;40(2):61-6
pubmed: 18358157
Rev Calid Asist. 2016 Nov - Dec;31(6):373-379
pubmed: 27174650
J Healthc Qual Res. 2018 Sep - Oct;33(5):270-277
pubmed: 30401422
Med Clin (Barc). 2014 Oct 7;143(7):309-13
pubmed: 25015252
Enferm Clin. 2014 Jul-Aug;24(4):211-8
pubmed: 24775466
Aten Primaria. 2013 Oct;45(8):404-8
pubmed: 23827795
Rev Calid Asist. 2013 Mar-Apr;28(2):109-16
pubmed: 22980755
Gac Sanit. 2012 Nov-Dec;26(6):570-3
pubmed: 22444520
Enferm Clin. 2008 Jan-Feb;18(1):11-7
pubmed: 18218262

Auteurs

Benjamín Herreros (B)

Instituto de Ética Clínica Francisco Vallés, Universidad Europea de Madrid, Madrid, Spain. benjaminherreros@gmail.com.
Unidad de Medicina Interna, Hospital Universitario Fundación Alcorcón, Calle Budapest 1, 28922, Alcorcón, Madrid, Spain. benjaminherreros@gmail.com.

María Benito (M)

Legal Medicine, Psychiatry and Pathology Department, Universidad Complutense , Plaza de Ramón y Cajal, s/n, 28040, Madrid, Spain.

Pablo Gella (P)

Instituto de Ética Clínica Francisco Vallés, Universidad Europea, Plaza de Francisco Morano, s/n, 28005, Madrid, Spain.

Emanuele Valenti (E)

Centre for Ethics in Medicine, Bristol Medical School, University of Bristol, 39 Whatley Road, Bristol, BS8 2PS, UK.

Beatriz Sánchez (B)

Unidad de Medicina Interna, Hospital Universitario Fundación Alcorcón, Calle Budapest 1, 28922, Alcorcón, Madrid, Spain.

Tayra Velasco (T)

Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense, Plaza de Ramón y Cajal, s/n, 28040, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH